Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, April 14, 2016

Primed Physical Therapy Enhances Recovery of Upper Limb Function in Chronic Stroke Patients

Whatever the hell this means. Doesn't say how long after the stroke this research was done. Or the objective damage these patients are trying to recover from. In other words this research is non reproducible because the starting point is not objectively known. Interesting that this stimulates the same side as the lesion when other research suggests stimulating the opposite side - contralesional.


Primed Physical Therapy Enhances Recovery of Upper Limb Function in Chronic Stroke Patients

  1. Suzanne J. Ackerley, PhD1
  2. Winston D. Byblow, PhD1
  3. P. Alan Barber, FRACP1,2
  4. Hayley MacDonald1
  5. Andrew McIntyre-Robinson1
  6. Cathy M. Stinear, PhD1
  1. 1University of Auckland, Auckland, New Zealand
  2. 2Auckland City Hospital, Auckland, New Zealand
  1. Cathy M. Stinear, PhD, Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Email: c.stinear@auckland.ac.nz

Abstract

Background. Recovery of upper limb function is important for regaining independence after stroke. Objective. To test the effects of priming upper limb physical therapy with intermittent theta burst stimulation (iTBS), a form of noninvasive brain stimulation.  
Methods. Eighteen adults with first-ever chronic monohemispheric subcortical stroke participated in this randomized, controlled, triple-blinded trial. Intervention consisted of priming with real or sham iTBS to the ipsilesional primary motor cortex immediately before 45 minutes of upper limb physical therapy, daily for 10 days. Changes in upper limb function (Action Research Arm Test [ARAT]), upper limb impairment (Fugl-Meyer Scale), and corticomotor excitability, were assessed before, during, and immediately, 1 month and 3 months after the intervention. Functional magnetic resonance images were acquired before and at one month after the intervention.  
Results. Improvements in ARAT were observed after the intervention period when therapy was primed with real iTBS, but not sham, and were maintained at 1 month. These improvements were not apparent halfway through the intervention, indicating a dose effect. Improvements in ARAT at 1 month were related to balancing of corticomotor excitability and an increase in ipsilesional premotor cortex activation during paretic hand grip.  
Conclusions. Two weeks of iTBS-primed therapy improves upper limb function at the chronic stage of stroke, for at least 1 month postintervention, whereas therapy alone may not be sufficient to alter function. This indicates a potential role for iTBS as an adjuvant to therapy delivered at the chronic stage.

No comments:

Post a Comment